Related Experiment Video
Updated: Jan 21, 2026

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
Functional association of a CD40 gene single-nucleotide polymorphism with the pathogenesis of coronary heart disease
Cheryl S Sultan1, Michael Weitnauer2, Martin Turinsky1
1Department of Cardiovascular Physiology, Institute of Physiology and Pathophysiology, Heidelberg University, Im Neuenheimer Feld 326, 69120 Heidelberg, Germany.
Insights
A specific CD40 gene variant (rs1883832) increases coronary heart disease (CHD) risk in Caucasians. This single-nucleotide polymorphism (SNP) promotes inflammation in endothelial cells, contributing to atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Genetics
- Immunology
Background:
- Endothelial dysfunction is central to atherosclerosis development.
- CD40-CD40 ligand interactions promote endothelial cell (EC) inflammation.
- A CD40 gene polymorphism (-1T>C, rs1883832) is linked to coronary heart disease (CHD) in Asians.
Purpose of the Study:
- Investigate the CD40 -1T>C single-nucleotide polymorphism (SNP) as a CHD risk factor in Caucasians.
- Elucidate the functional impact of this SNP on cultured endothelial cells.
Main Methods:
- Genotype-stratified human EC characterization using molecular and biochemical techniques.
- Cell adhesion assays to assess monocyte binding.
- Case-control study in Caucasians to examine SNP distribution and CHD association.
- ELISA quantification of soluble CD40 (sCD40) levels.
Main Results:
- The CD40 SNP impacts baseline CD40 protein levels on ECs.
- Genotype-dependent differences in CD40-mediated pro-inflammatory gene expression were observed.
- Homozygosity for the C allele significantly increased CHD odds (2.32-fold) and monocyte adhesion.
- Elevated sCD40 plasma levels in CHD patients correlated with genotype.
Conclusions:
- The C allele of the CD40 SNP induces a pro-inflammatory EC phenotype.
- Enhanced CD40 shedding may compensate for increased CD40 ligand interaction.
- Homozygosity for the C allele confers genetic susceptibility to atherosclerosis.
Aims:
Endothelial dysfunction is a major contributor to the pathogenesis of atherosclerosis. CD40-CD40 ligand interactions confer a pro-inflammatory phenotype to endothelial cells (ECs). Recently, a thymine to cytosine transition (-1T>C) in the Kozak sequence of the CD40 gene (rs1883832) has been associated with coronary heart disease (CHD) in an Asian population. As there are no reports yet regarding its role in other ethnic groups, this study determines if the -1T>C single-nucleotide polymorphism (SNP) could be a risk factor for CHD in Caucasians by performing an association study and elucidates its functional consequence in cultured ECs.
Methods And Results:
Molecular and biochemical techniques, cell adhesion assays were used for genotype-stratified human EC characterization. SNP distribution in Caucasians was examined in a hospital-based case-control CHD study and serum levels of soluble CD40 (sCD40) were quantified by ELISA. The SNP in the CD40 gene affected baseline CD40 protein abundance on ECs. There was a genotype-dependent difference in CD40-mediated expression of pro-inflammatory genes. Monocyte adhesion was highest on the surface of cells homozygous for the C allele. Homozygosity for the C allele was associated with significant 2.32-fold higher odds of developing CHD as compared to TT genotype carriers. sCD40 plasma levels were genotype-dependently elevated in CHD patients, indicating a possible prognostic value.
Conclusion:
The C allele of the CD40 SNP provokes a pro-inflammatory EC phenotype, compensated by an enhanced CD40 shedding to neutralize excess CD40 ligand. Homozygosity for the C allele is the cause for a genetic susceptibility to atherosclerosis and its sequelae.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Nucleotide Excision Repair
Rheumatic Heart Disease I: Introduction

